BioStem Technologies Highlights Alignment with FDA’s Openness to Bayesian Statistical Approaches in Clinical Research

BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of perinatal tissue derived products for advanced wound care, today ...
JD Supra

AML/Financial Crime In The UK And EU: Regulatory Priorities And Timelines For 2026–2028

In this article we explore the latest developments in AML and Financial crime across the UK and EU, including the reform of the UK’s Money ...